Peyvandi F, Duga S, Akhavan S, Mannucci P M
The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and the Fondazione Luigi Villa, Department of Internal Medicine, IRCCS Maggiore Hospital and University of Milano, Italy.
Haemophilia. 2002 May;8(3):308-21. doi: 10.1046/j.1365-2516.2002.00633.x.
Deficiencies of coagulation factors (other than factor VIII and factor IX) that cause a bleeding disorder are inherited as autosomal recessive traits and are generally rare, with prevalences in the general population varying between 1 : 500 000 and 1 : 2 000 000. In the last few years, the number of patients with recessively transmitted coagulation deficiencies has increased in European countries with a high rate of immigration of Islamic populations, because in these populations, consanguineous marriages are frequent. Owing to the relative rarity of these deficiencies, the type and severity of bleeding symptoms, the underlying molecular defects and the actual management of bleeding episodes are not as well established as for haemophilia A and B. This article reviews these disorders in terms of their clinical manifestations and characterization of the molecular defects involved. The general principles of management are also discussed.
afibrinogenaemia, autosomal recessive disorders, factor VIII, factor XI, factor XIII.
导致出血性疾病的凝血因子(除因子VIII和因子IX外)缺乏症以常染色体隐性遗传特征遗传,通常较为罕见,在普通人群中的患病率在1:500000至1:2000000之间。在过去几年中,在伊斯兰人口移民率较高的欧洲国家,隐性遗传凝血因子缺乏症患者的数量有所增加,因为在这些人群中近亲结婚很常见。由于这些缺乏症相对罕见,出血症状的类型和严重程度、潜在的分子缺陷以及出血发作的实际处理方法不像甲型和乙型血友病那样明确。本文根据其临床表现和所涉及的分子缺陷特征对这些疾病进行综述。还讨论了治疗的一般原则。
无纤维蛋白原血症、常染色体隐性疾病、因子VIII、因子XI、因子XIII。